In 2024, PolyPeptide made substantial progress in restoring profitability. The gross profit for 2024 was EUR 39.3 million versus EUR 9.1 million in 2023, and EBITDA was EUR 25.4 million versus EUR ...

PolyPeptide's path to reclaiming profitability that aligns with its peers is supported by significant growth drivers in the market, including demand for GLP-1 API. Barclays forecasts that fiscal ...

In a report released on February 24, Charles Weston from RBC Capital maintained a Buy rating on PolyPeptide Group AG (PPGN – Research Report), ...

Investing.com -- Shares of PolyPeptide Group AG (SWX:SIX:PPGN) fell by 12% following the release of their 2024 financial results, which revealed a miss on revenue expectations, although EBITDA ...

When connected together by a series of peptide bonds, amino acids form a polypeptide, another word for protein. The polypeptide will then fold into a specific conformation depending on the ...

Investing.com -- Shares of PolyPeptide Group AG (SWX:SIX: PPGN) fell by 12% following the release of their 2024 financial results, which revealed a miss on revenue expectations, although EBITDA ...